Instrument Inactif

Communiqués RIV Capital Inc. OTC Markets

Actions

CNPOF

CA7680141024

Produits pharmaceutiques

Communiqués

19/12/24	CSE Bulletin: Delist - RIV Capital Inc. (RIV)	NE
19/12/24	Canadian Investment Regulatory Organization Trading Halt - RIV	AQ
26/11/24	Cansortium Inc. Completes New Senior Secured Credit Agreement Ahead of Planned Business Combination Closing with RIV Capital	AQ
27/07/24	RIV Capital : Notice and Access Notification	PU
30/05/24	Canadian Investment Regulatory Organization Trade Resumption - RIV	AQ
30/05/24	ScottsMiracle-Gro Poised to Advance Cannabis Strategy in New York, Florida and other states	AQ
30/05/24	RIV Capital Reports Financial Results for the First Quarter Ended March 31, 2024	AQ
30/05/24	Cansortium and RIV Capital Announce Business Combination	AQ
30/05/24	Canadian Investment Regulatory Organization Trading Halt - RIV	AQ
01/05/24	RIV Capital Applauds Reports that DEA Plans to Reschedule Cannabis	AQ
22/04/24	RIV Capital Sets Date for Financial Results for the Fiscal Quarter and Nine-Month Transition Year Ended December 31, 2023	AQ
11/12/23	RIV Capital Inc. - Etain obtains approval to commence sales to New York's adult-use market	AQ
01/08/23	Etain Receives Regulatory Approval for Flagship Facility in Buffalo, New York	AQ
15/05/23	RIV Capital provides update on revised New York cannabis market draft regulations and operational milestones	AQ
01/03/23	RIV Capital Reports Fiscal Third Quarter 2023 Financial Results	AQ
23/02/23	IIROC Trade Resumption - RIV	AQ
23/02/23	IIROC Trading Halt - RIV	AQ
20/12/22	RIV Capital's Largest Shareholder, JW Asset Management, Requisitions Special Meeting to Address Necessary Leadership Changes	AQ
29/11/22	RIV Capital Reports Fiscal Second Quarter 2023 Financial Results	AQ
09/11/22	RIV Capital Issues Statement on New York's Gubernatorial Election	AQ
30/08/22	RIV Capital Reports First Quarter 2023 Financial Results	AQ
23/08/22	RIV Capital Signs Lease for Flagship Cannabis Cultivation and Manufacturing Facility in Buffalo, New York	AQ
30/03/22	RIV Capital buys New York cannabis chain Etain for US$247 million	AQ
18/11/21	RIV Capital : 52-109F2 - Certification of interim filings - CFO (E)	PU
20/08/21	CSE Bulletin: New Listing - RIV Capital Inc. (RIV)	NE